Dosing psychedelics and potential drug-drug interactions by Professor Matthias Liechti at the Alps Conference 2022

This interview was recorded during the Alps Conference 2022 on psychedelic research in Bern, Switzerland on 29.10.2022. More info on the Alps Conference 2022 - Website - Twitter - Facebook - Instagram - Youtube

Matthias Liechti is a professor of clinical pharmacology and internal medicine at the University Hospital Basel. With his psychopharmacology research team he investigates the pharmacology of psychoactive substances both in vitro and in humans. The team also conducts Pharmaco-fMRI studies and is conducting Phase 2 studies with LSD in patients with cluster headache, major depression, and anxiety disorder in collaboration with the respective disease specialists.

For more information on Mathias : 

Website :  Matthias Liechti
Universitätsspital Basel